ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Aarey Drugs & Pharmaceuticals Ltd filed its quarterly shareholding pattern. This is a routine regulatory compliance disclosure regarding the company's equity distribution.
Aarey Drugs approved the Board Report and called its 36th Annual General Meeting to be held on September 30, 2026.
Aarey Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹44.6 Cr (-56.4% YoY) and net profit of ₹1 Cr (-28.6% YoY) for Q1 FY27.
Aarey Drugs & Pharmaceuticals will hold a board meeting on August 14, 2026, to consider and approve the standalone unaudited financial results for the June 2026 quarter.
Aarey Drugs allotted 25.20 lakh equity shares upon conversion of warrants, raising Rs. 12.06 Crore. This issuance changes the company's paid-up equity capital.
The company has filed its quarterly shareholding pattern for the period ending June 30, 2026, as per regulatory requirements.